What are the dosing guidelines for intramuscular (IM) Biotin 0.5mg/ml in a patient with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Biotin is Not Recommended

Intramuscular biotin administration is not supported by current clinical guidelines and should not be used. The ESPEN guidelines establish oral biotin as first-line treatment for biotin deficiency, with intravenous biotin reserved exclusively for parenteral nutrition-dependent patients 1.

Guideline-Based Route Selection

The evidence clearly delineates appropriate routes of administration:

  • Oral biotin is the recommended first-line treatment for biotin deficiency, including cases of malabsorption or short bowel syndrome (requiring increased doses up to 10 mg/day) 1
  • Intravenous biotin is reserved exclusively for parenteral nutrition-dependent patients, with doses up to 200 mg/day for 2-3 weeks 1
  • Intramuscular administration is notably absent from guidelines—the American Society for Parenteral and Enteral Nutrition does not mention IM biotin administration in its guidelines, despite explicitly discussing IM routes for other micronutrients like vitamin D 1

Standard Dosing for Appropriate Routes

Since IM biotin lacks guideline support, the appropriate alternatives are:

For Oral Administration (Preferred):

  • Maintenance dose: At least 30 mcg/day (Grade B recommendation) 1
  • Deficiency treatment: 10 mg/day for malabsorption/short bowel cases 1
  • Absorption: Nearly complete in humans, even in malabsorption states 2

For IV Administration (PN-dependent patients only):

  • Maintenance dose: 60 mcg/day (Grade B recommendation) 1
  • Deficiency treatment: Up to 200 mg/day for 2-3 weeks 1

Clinical Pitfalls

Common error: Assuming IM biotin is appropriate because a 0.5 mg/ml formulation exists. The absence of IM biotin from major nutrition society guidelines, despite explicit mention of IM routes for other vitamins, indicates this route is not evidence-based 1.

Safety consideration: While biotin has no established upper limit and no adverse effects reported with doses up to 5 mg/day for prolonged periods 1, 3, this safety profile applies to oral and IV routes only.

Renal Function Considerations

For patients with normal renal function (as specified in your question):

  • Standard oral dosing applies without adjustment 1
  • Renal replacement therapy may require additional biotin amounts, but this does not apply to your patient 1

References

Guideline

Biotin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Biotin biochemistry and human requirements.

The Journal of nutritional biochemistry, 1999

Guideline

Biotin Interference with Thyroid Function Tests

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.